Access
This article is part of Nature's premium content.
Published online 14 December 2004 | Nature | doi:10.1038/news041213-3
News
SARS vaccine trial spotlights continued peril
Vigilance remains but other infectious diseases loom large.
Two years ago, a lethal virus was brewing in rural China, one that was subsequently dubbed SARS, for severe acute respiratory syndrome. Now a new vaccine against the disease is being tested in humans - at a time when it is at risk of drifting off the public-health radar.
To read this story in full you will need to login or make a payment (see right).
Comments
Reader comments are usually moderated after posting. If you find something offensive or inappropriate, you can speed this process by clicking 'Report this comment' (or, if that doesn't work for you, email webadmin@nature.com). For more controversial topics, we reserve the right to moderate before comments are published.
There are currently no comments.
